Literature DB >> 27475335

Improved healthcare economic outcomes after liposomal bupivacaine administration in first-stage breast reconstruction.

Suzette G Miranda1, Yusha Liu1, Shane D Morrison1, Ravi F Sood2, Thomas Gallagher3, Alexander J Gougoutas1, Shannon M Colohan1, Otway Louie1, David W Mathes4, Peter C Neligan1, Hakim K Said5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27475335     DOI： 10.1016/j.bjps.2016.06.031

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN： 1748-6815            Impact factor:   2.740


× No keyword cloud information.
  3 in total

1.  Liposomal Bupivacaine in Implant-Based Breast Reconstruction.

Authors:  Saba Motakef; Wendy W Wong; Michael J Ingargiola; David Nguyen; Izabela A Galdyn; Hahns Y Kim; Subhas C Gupta
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-11-20

2.  Does Subcutaneous Infiltration of Liposomal Bupivacaine Following Single-Level Transforaminal Lumbar Interbody Fusion Surgery Improve Immediate Postoperative Pain Control?

Authors:  Marko Tomov; Kevin Tou; Rose Winkel; Ross Puffer; Mohamad Bydon; Ahmad Nassr; Paul Huddleston; Michael Yaszemski; Bradford Currier; Brett Freedman
Journal:  Asian Spine J       Date:  2018-02-07

Review 3.  Perioperative Blocks for Decreasing Postoperative Narcotics in Breast Reconstruction.

Authors:  Ariel Clare Johnson; Salih Colakoglu; Angela Reddy; Clara Marie Kerwin; Roland A Flores; Matthew L Iorio; David W Mathes
Journal:  Anesth Pain Med       Date:  2020-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.